This is because HF is in the majority of cases the principal life-limiting disease and priority to HF treatment should be given
This is because HF is in the majority of cases the principal life-limiting disease and priority to HF treatment should be given. usually older and are frequently under-represented into randomized controlled trials.26C28 Often, several comorbidities are present at the same time in the same patient limiting leading to poly-pharmacy and limiting the adherence and tolerability … [Read more…]